why do glp 1 agonists cause nausea Frontiers GLP-1 Causing Nausea: Navigating Side
Description
Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia
34.5 per 100,000 person-years, HR 1.75, 95% CI 1.222.49) in a population-based study [107]
Tirzepatide concentrations in compounded forms commonly range from 10 mg/mL to 60 mg/mL
Such variability likely reflects additional factors, including aging, obesity, hypertension, and dyslipidemia, that compound kidney injury and accelerate its progression
Khaity, A
